Previous 10 | Next 10 |
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will report financial results for the third quarter of 2023 after market close on Monday, November 6, 2023. Company management will be webcasting a corresponding conference call beginning at 1:30...
Not intended for distribution to U.S. newswire services or for dissemination in the U.S. RED DEER, AB / ACCESSWIRE / October 16, 2023 / Gamehost Inc. ('Gamehost', the 'Company') (TSX:GH) Gamehost has declared a cash dividend for the month of October 2023 of $0.03 (CDN) per common share, whi...
2023-10-11 09:53:00 ET Equity markets tend to be volatile and unpredictable over short periods of one year or less. But over five years or more, things change. Indexes usually show sustained growth the more one zooms out. Of course, that doesn't mean every stock delivers excellent returns -...
2023-10-08 07:30:00 ET Exact Sciences (NASDAQ: EXAS) and Guardant Health (NASDAQ: GH) make diagnostic tests to help screen for cancer. The two healthcare stocks have similar price-to-sales (P/S) ratios, and over the past five years, nearly identical high-growth profiles....
2023-10-05 17:01:30 ET Summary Guardant Health's market values remain depressed, posing questions about its investment potential. The company offers precision oncology tests and has commercially launched several tests for advanced-stage cancer. Using a sound economic framework...
2023-10-01 16:02:12 ET Bernstein is bullish on medtech stocks Thermo Fisher, Guardant Health, Revvity and PacBio, but sees further downside for Illumina, according to a new industry note. The investment firm kicked off coverage of the US life science tools and diagnostics sector last we...
2023-09-28 16:22:28 ET Shares of Guardant Health (NASDAQ: GH) are up 16.2% this week as of Thursday's close, according to data provided by S&P Global Market Intelligence , on the heels of multiple analyst upgrades for the precision oncology stock. Guardant Health rallied...
2023-09-28 11:25:05 ET With a stock down nearly 50% over the last 52 weeks, investors in Guardant Health (NASDAQ: GH) haven't had a lot to cheer about this year. The last couple of days, however, may be changing that. This morning, an endorsement from investment bank Bernstein s...
2023-09-27 15:41:37 ET More on Guardant Health Guardant Health, Inc. (GH) Q2 2023 Earnings Call Transcript Guardant Health, Inc. 2023 Q2 - Results - Earnings Call Presentation Guardant Health: A Growth Company Expanding Its Product Line Quickly Guardant Healt...
2023-09-26 10:50:17 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 26, 2023 – USA News Group – The seriousness of pancreatic cancer continues to grow, with increasing alarm since The Lancet published an ...
News, Short Squeeze, Breakout and More Instantly...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2024 after market close on Wednesday, August 7, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Ti...
Running on Guardant Infinity™ smart liquid biopsy platform, new Guardant360 test covers over 10 times more genes, including all guideline-recommended genomic biomarkers across advanced solid tumors, and quantifies tumor burden with 10 times higher sensitivity Upgraded test covered ...
2024-07-21 23:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...